Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.

Aims: Drug-eluting stents (DES) represent a major advance in interventional cardiology. Along with the success shown, current DES also present limitations related to the presence of polymer-coating, fixed drug, and dose used. With the ISAR (Individualized Drug-Eluting Stent System to Abrogate Restenosis) project, a DES system has been developed that permits individualized choice of the drug and dose to use for the given patient.

Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.

Objective: The risk of in-stent restenosis can be considerably reduced by stents eluting cytostatic compounds. We created a novel drug-eluting stent system that includes several new features in the rapidly evolving field of stent-based drug delivery.

Methods And Results: The aim of the present study was the preclinical evaluation of a stent-coating system permitting individual, on-site coating of stents with a unique microporous surface allowing for individualizable, dose-adjustable, and multiple coatings with identical or various compounds, designated ISAR (individualizable drug-eluting stent system to abrogate restenosis).

The effect of simulated body fluid on the mechanical properties of multiblock poly(aliphatic/aromatic-ester) copolymers.

The effects of simulated body fluid (SBF) on the surface and mechanical properties of poly(aliphatic/aromatic-ester) (PED) copolymers were investigated. PED copolymers containing different hard (aromatic) and soft (aliphatic) segment weight ratios were exposed to SBF for 52 days, and afterwards their mechanical properties were evaluated. A quasi-static tensile test estimating relaxation and fatigue properties from the hysteresis method was performed.